Pakistan’s retail pharma sector surpasses Rs1.049 trillion in salesÂ
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
Pakistan loses up to Rs50bn annually to unethical drug marketing, say DRAP officialsÂ
DRAP CEO says irrational drug use accounts for nearly a quarter of Pakistan’s total health budget and is accelerating antimicrobial resistanceÂ
Saudi investors exit Pakistan’s largest pharmacy chain. What happened and why?
From its origins as part of the Servis Group to multiple changes in ownership since its inception in 2005, Servaid has undergone an eventful two decades in existence
Pharmaceuticals: how the locals are beating the multinationals
In a heavily regulated market, the local players have learned to live with the price rules the way they are, while the foreign players still seem to have hope that things will change
BF Biosciences expands production, launches diabetes treatment, secures listing approval
Company receives approval for brownfield expansion and launches Sematide, a new diabetes treatment, while listing application is greenlit by SECP and PSX
DRAP’s survey on drug price hikes irks pharmaceutical manufacturers
Third-party survey initiated in response to public outcry over rising medicine prices after deregulation of non-essential drugs; PPMA voices concerns over lack of industry stakeholder involvement
Pharma sector thrives with 21.79% growth amid economic stagnation
Deregulation policy drives record sales, but patients face rising costs
Searle is lagging the pharmaceutical sector. Its recovery might be just around the corner
The pharmaceutical company has had lackluster numbers in recent times. All that might be about to change
The mechanics behind the panadol shortage
Raids, hoarding and over regulating — You probably need a Panadol to figure out what’s going on
Pakistan’s pharmaceutical exports hit 34% growth in FY25, marking a two-decade high
Exports of locally produced medicines reach $457 million, with deregulation policy boosting growth
Haleon Pakistan ships first consignment of Centrum multivitamin to Kenya
Shipment marks Pakistan's growing pharmaceutical exports and opens new international trade avenues.
Searle to sell its entire shareholding in Pakistani subsidiary Â
Board approves sale of 90.61% stake to IJARA-led consortium
Pakistan’s medicinal imports rise by 9.74pc
ISLAMABAD: Pakistan imported medicinal product worth $656.092 million during the first seven months of current fiscal year, showing growth of 9.74 per...
Ferozsons launches biologic to treat diabetes
Pharmaceutical company’s biotech subsidiary to launch the new product in one of Pakistan’s biggest therapeutic areas
Searle secures DRAP’s approval for Denosumab biosimilar injections
Company prepares commercial rollout of 60mg and 120mg doses for osteoporosis and oncology care